PAPER Popescu BO, Cedazo-Minguez A, Popescu LM, Winblad B, Cowburn RF, Ankarcrona M
SEARCH RESULTS
345052 RESULTS
PAPER Halliwell B
Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
Drugs Aging. 2001;18(9):685-716. PubMed.PAPER Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C
Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases.
Ann Neurol. 2001 Oct;50(4):434-42. PubMed.PAPER Carter DB, Dunn E, McKinley DD, Stratman NC, Boyle TP, Kuiper SL, Oostveen JA, Weaver RJ, Boller JA, Gurney ME
Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.
Ann Neurol. 2001 Oct;50(4):468-75. PubMed.PAPER Liu WK, Le TV, Adamson J, Baker M, Cookson N, Hardy J, Hutton M, Yen SH, Dickson DW
Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy.
Ann Neurol. 2001 Oct;50(4):494-502. PubMed.PAPER Neumann M, Schulz-Schaeffer W, Crowther RA, Smith MJ, Spillantini MG, Goedert M, Kretzschmar HA
Pick's disease associated with the novel Tau gene mutation K369I.
Ann Neurol. 2001 Oct;50(4):503-13. PubMed.PAPER Vitiello MV, Borson S
Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.
CNS Drugs. 2001;15(10):777-96. PubMed.PAPER Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH
Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.
Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30. PubMed.PAPER Ellis KA, Nathan PJ
The pharmacology of human working memory.
Int J Neuropsychopharmacol. 2001 Sep;4(3):299-313. PubMed.PAPER Sakaguchi M, Miyazaki M, Kondo T, Namba M
Up-regulation of S100C in normal human fibroblasts in the process of aging in vitro.
Exp Gerontol. 2001 Aug;36(8):1317-25. PubMed.PAPER Zhang L, Xing GQ, Barker JL, Chang Y, Maric D, Ma W, Li BS, Rubinow DR
Alpha-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway.
Neurosci Lett. 2001 Oct 26;312(3):125-8. PubMed.PAPER Sang H, Lu Z, Li Y, Ru B, Wang W, Chen J
Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.
Neurosci Lett. 2001 Oct 26;312(3):141-4. PubMed.PAPER Abe T, Tohgi H, Murata T, Isobe C, Sato C
Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.
Neurosci Lett. 2001 Oct 26;312(3):177-9. PubMed.PAPER Tsolaki M, Kokarida K, Iakovidou V, Stilopoulos E, Meimaris J, Kazis A
Extrapyramidal symptoms and signs in Alzheimer's disease: prevalence and correlation with the first symptom.
Am J Alzheimers Dis Other Demen. 2001 Sep-Oct;16(5):268-78. PubMed.PAPER Hu J, Igarashi A, Kamata M, Nakagawa H
Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.
J Biol Chem. 2001 Dec 21;276(51):47863-8. PubMed.Current Filters
No filters selected